Boerhaave syndrome epidemiology and demographics

Boerhaave syndrome Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Boerhaave syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Boerhaave syndrome epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Boerhaave syndrome epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Boerhaave syndrome epidemiology and demographics
CDC on Boerhaave syndrome epidemiology and demographics
Boerhaave syndrome epidemiology and demographics in the news
Blogs on Boerhaave syndrome epidemiology and demographics
Directions to Hospitals Treating Boerhaave syndrome
Risk calculators and risk factors for Boerhaave syndrome epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Epidemiology and Demographics

Age

Boerhaave syndrome is most frequently seen among patients 50-70 years of age, and least susceptible age group is 1-17 years.

Gender

Boerhaave syndrome occurs more in men than women by a ratios ranging from 2:1 to 5:1.